These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 17052277

  • 1. Associations of tumour necrosis factor alpha promoter polymorphisms at position -308 and -238 with clinical characteristics of chronic hepatitis C.
    Dai CY, Chuang WL, Lee LP, Chen SC, Hou NJ, Lin ZY, Hsieh MY, Hsieh MY, Wang LY, Chang WY, Yu ML.
    J Viral Hepat; 2006 Nov; 13(11):770-4. PubMed ID: 17052277
    [Abstract] [Full Text] [Related]

  • 2. Association of TNF-beta polymorphism with disease severity among patients infected with hepatitis C virus.
    Goyal A, Kazim SN, Sakhuja P, Malhotra V, Arora N, Sarin SK.
    J Med Virol; 2004 Jan; 72(1):60-5. PubMed ID: 14635012
    [Abstract] [Full Text] [Related]

  • 3. [Association between genetic polymorphism of tumor necrosis factor and chronic severe hepatitis B in patients].
    Li Z, Li HQ, Yan Y, Liu Y, Hao W, Niu JQ, Yin JM, Li H.
    Zhonghua Yi Xue Za Zhi; 2007 Aug 14; 87(30):2105-8. PubMed ID: 17988528
    [Abstract] [Full Text] [Related]

  • 4. Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection.
    Dai CY, Chuang WL, Chang WY, Chen SC, Lee LP, Hsieh MY, Hou NJ, Lin ZY, Huang JF, Hsieh MY, Wang LY, Yu ML.
    J Infect Dis; 2006 Jan 01; 193(1):98-101. PubMed ID: 16323137
    [Abstract] [Full Text] [Related]

  • 5. Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C.
    Rosen HR, McHutchison JG, Conrad AJ, Lentz JJ, Marousek G, Rose SL, Zaman A, Taylor K, Chou S.
    Am J Gastroenterol; 2002 Mar 01; 97(3):714-20. PubMed ID: 11922568
    [Abstract] [Full Text] [Related]

  • 6. Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection.
    Yee LJ, Tang J, Herrera J, Kaslow RA, van Leeuwen DJ.
    Genes Immun; 2000 Aug 01; 1(6):386-90. PubMed ID: 11196686
    [Abstract] [Full Text] [Related]

  • 7. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
    Hsieh MY, Dai CY, Lee LP, Huang JF, Tsai WC, Hou NJ, Lin ZY, Chen SC, Wang LY, Chang WY, Chuang WL, Yu ML.
    J Clin Pathol; 2008 Mar 01; 61(3):333-7. PubMed ID: 17545561
    [Abstract] [Full Text] [Related]

  • 8. Lack of effect of tumor necrosis factor-alpha -308 G/A polymorphism on severity of liver fibrosis in Tunisian hepatitis C virus (HCV)-infected patients.
    Bouzgarrou N, Hassen E, Gabbouj S, Schvoerer E, Ben Mami N, Triki H, Chouchane L.
    Gastroenterol Clin Biol; 2010 Mar 01; 34(4-5):297-304. PubMed ID: 20537485
    [Abstract] [Full Text] [Related]

  • 9. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms.
    Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee JH, Park CS, Lee JE, Hahm KB, Kim JH.
    J Gastroenterol Hepatol; 2006 Jul 01; 21(7):1163-9. PubMed ID: 16824070
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association of functional polymorphism of ApoB promoter with hepatitis C virus infection.
    Zhu C, Zhang R, Liu D, Mukhtar MM, Liu W, Peng G, Wang K, Hao Q, Xu Y, Liu F, Zhu Y, Wu J.
    Clin Chim Acta; 2009 Mar 01; 401(1-2):124-7. PubMed ID: 19083997
    [Abstract] [Full Text] [Related]

  • 13. Association between transforming growth factor-beta 1 polymorphism and virologic characteristics of chronic hepatitis C.
    Dai CY, Chuang WL, Lee LP, Pan WC, Huang JF, Hsieh MY, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Yu ML.
    Transl Res; 2008 Oct 01; 152(4):151-6. PubMed ID: 18940717
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Alleles -308A and -1031C in the TNF-alpha gene promoter do not increase the risk but associated with circulating levels of TNF-alpha and clinical features of vivax malaria in Indian patients.
    Sohail M, Kaul A, Bali P, Raziuddin M, Singh MP, Singh OP, Dash AP, Adak T.
    Mol Immunol; 2008 Mar 01; 45(6):1682-92. PubMed ID: 17996942
    [Abstract] [Full Text] [Related]

  • 16. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations.
    El-Shabrawi Y, Wegscheider BJ, Weger M, Renner W, Posch U, Ulrich S, Ardjomand N, Hermann J.
    Ophthalmology; 2006 Apr 01; 113(4):695-700. PubMed ID: 16581430
    [Abstract] [Full Text] [Related]

  • 17. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection.
    Kim YJ, Lee HS, Yoon JH, Kim CY, Park MH, Kim LH, Park BL, Shin HD.
    Hum Mol Genet; 2003 Oct 01; 12(19):2541-6. PubMed ID: 12915457
    [Abstract] [Full Text] [Related]

  • 18. Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection.
    Barrett S, Collins M, Kenny C, Ryan E, Keane CO, Crowe J.
    J Med Virol; 2003 Oct 01; 71(2):212-8. PubMed ID: 12938195
    [Abstract] [Full Text] [Related]

  • 19. The -670A > G polymorphism in the promoter region of the FAS gene is associated with necrosis in periportal areas in patients with chronic hepatitis C.
    Aguilar-Reina J, Ruiz-Ferrer M, Pizarro MA, Antiñolo G.
    J Viral Hepat; 2005 Nov 01; 12(6):568-73. PubMed ID: 16255757
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan.
    Kusumoto K, Uto H, Hayashi K, Takahama Y, Nakao H, Suruki R, Stuver SO, Ido A, Tsubouchi H.
    Cytokine; 2006 Apr 01; 34(1-2):24-31. PubMed ID: 16698276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.